Assertio Therapeutics, Inc. (ASRT): Price and Financial Metrics

Assertio Therapeutics, Inc. (ASRT): $2.17

-0.12 (-5.24%)

POWR Rating

Component Grades














  • Value is the dimension where ASRT ranks best; there it ranks ahead of 99.45% of US stocks.
  • ASRT's strongest trending metric is Growth; it's been moving down over the last 177 days.
  • ASRT's current lowest rank is in the Stability metric (where it is better than 7.86% of US stocks).

ASRT Stock Summary

  • With a price/earnings ratio of 4.1, ASSERTIO HOLDINGS INC P/E ratio is greater than that of about just 9.63% of stocks in our set with positive earnings.
  • The price/operating cash flow metric for ASSERTIO HOLDINGS INC is higher than merely 8.7% of stocks in our set with a positive cash flow.
  • Over the past twelve months, ASRT has reported earnings growth of -184.5%, putting it ahead of just 8.65% of US stocks in our set.
  • Stocks that are quantitatively similar to ASRT, based on their financial statements, market capitalization, and price volatility, are STKS, DXC, RUTH, SHEN, and NNBR.
  • ASRT's SEC filings can be seen here. And to visit ASSERTIO HOLDINGS INC's official web site, go to

ASRT Valuation Summary

  • ASRT's price/sales ratio is 0.8; this is 82.8% lower than that of the median Healthcare stock.
  • ASRT's price/earnings ratio has moved up 5.9 over the prior 243 months.

Below are key valuation metrics over time for ASRT.

Stock Date P/S P/B P/E EV/EBIT
ASRT 2022-09-23 0.8 0.8 4.1 3.1
ASRT 2022-09-22 0.8 0.8 4.3 3.2
ASRT 2022-09-21 0.8 0.8 4.2 3.1
ASRT 2022-09-20 0.8 0.8 4.3 3.2
ASRT 2022-09-19 0.8 0.8 4.3 3.2
ASRT 2022-09-16 0.9 0.9 4.5 3.4

ASRT Growth Metrics

    Its 5 year cash and equivalents growth rate is now at 17.28%.
  • Its 5 year price growth rate is now at -96.2%.
  • Its 5 year revenue growth rate is now at -56.56%.
Over the past 15 months, ASRT's revenue has gone up $18,272,000.

The table below shows ASRT's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-06-30 130.469 50.641 25.241
2022-03-31 120.711 37.175 3.238
2021-12-31 111.014 5.523 -1.281
2021-09-30 107.86 -4.59 -30.241
2021-06-30 116.953 -23.675 -44.5
2021-03-31 112.197 -44.735 -64.83

ASRT's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • ASRT has a Quality Grade of C, ranking ahead of 35.61% of graded US stocks.
  • ASRT's asset turnover comes in at 0.367 -- ranking 129th of 680 Pharmaceutical Products stocks.
  • NOVN, ARWR, and RIOT are the stocks whose asset turnover ratios are most correlated with ASRT.

The table below shows ASRT's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.367 0.819 -1.136
2021-03-31 0.343 0.800 -1.673
2020-12-31 0.354 0.813 -0.761
2020-09-30 0.380 0.884 -1.944
2020-06-30 0.337 0.927 -1.098
2020-03-31 0.332 0.957 -0.485

ASRT Price Target

For more insight on analysts targets of ASRT, see our ASRT price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $6.20 Average Broker Recommendation 1.5 (Moderate Buy)

ASRT Stock Price Chart Interactive Chart >

Price chart for ASRT

ASRT Price/Volume Stats

Current price $2.17 52-week high $4.44
Prev. close $2.29 52-week low $0.85
Day low $2.13 Volume 598,100
Day high $2.27 Avg. volume 1,030,986
50-day MA $3.02 Dividend yield N/A
200-day MA $2.71 Market Cap 104.55M

Assertio Therapeutics, Inc. (ASRT) Company Bio

Assertio Therapeutics, Inc. (formerly DepoMed) develops products for pain and other central nervous system conditions in the United States. The company was founded in 1995 and is focused in Newark, California.

ASRT Latest News Stream

Event/Time News Detail
Loading, please wait...

ASRT Latest Social Stream

Loading social stream, please wait...

View Full ASRT Social Stream

Latest ASRT News From Around the Web

Below are the latest news stories about ASSERTIO HOLDINGS INC that investors may wish to consider to help them evaluate ASRT as an investment opportunity.

Assertio (ASRT) Flat As Market Sinks: What You Should Know

Assertio (ASRT) closed at $2.24 in the latest trading session, marking no change from the prior day.

Yahoo | September 20, 2022

Is Most-Watched Stock Assertio Holdings, Inc. (ASRT) Worth Betting on Now?

Recently, users have been paying close attention to Assertio (ASRT). This makes it worthwhile to examine what the stock has in store.

Yahoo | September 13, 2022

Assertio (ASRT) Gains But Lags Market: What You Should Know

Assertio (ASRT) closed at $2.74 in the latest trading session, marking a +1.3% move from the prior day.

Yahoo | September 9, 2022

Has Assertio (ASRT) Outpaced Other Medical Stocks This Year?

Here is how Assertio (ASRT) and Axonics Modulation Technologies (AXNX) have performed compared to their sector so far this year.

Yahoo | September 7, 2022

Assertio to Participate in the 2022 Lake Street BIG6 Conference

LAKE FOREST, Ill., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. ("Assertio" or the "Company") (Nasdaq: ASRT), a specialty pharmaceutical company offering differentiated products to patients, today announced that Dan Peisert, CEO, will host investor meetings September 14, 2022 as part of the Lake Street Capital Markets Best Ideas Growth Conference (BIG6), taking place at The Yale Club in New York City. As part of the conference event, management will host one-on-one meetings through

Yahoo | September 7, 2022

Read More 'ASRT' Stories Here

ASRT Price Returns

1-mo -14.90%
3-mo -31.11%
6-mo -22.50%
1-year 139.51%
3-year -55.89%
5-year -90.63%
YTD -0.46%
2021 52.40%
2020 -71.39%
2019 -65.37%
2018 -55.16%
2017 -55.33%

Continue Researching ASRT

Here are a few links from around the web to help you further your research on Assertio Therapeutics Inc's stock as an investment opportunity:

Assertio Therapeutics Inc (ASRT) Stock Price | Nasdaq
Assertio Therapeutics Inc (ASRT) Stock Quote, History and News - Yahoo Finance
Assertio Therapeutics Inc (ASRT) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.6446 seconds.